Pacer Advisors Inc. Sells 145 Shares of Danaher Co. (NYSE:DHR)

Pacer Advisors Inc. cut its stake in shares of Danaher Co. (NYSE:DHR) by 0.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 50,965 shares of the conglomerate’s stock after selling 145 shares during the period. Pacer Advisors Inc.’s holdings in Danaher were worth $11,699,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Decker Retirement Planning Inc. purchased a new position in Danaher during the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America bought a new stake in shares of Danaher during the 3rd quarter worth $39,000. MidAtlantic Capital Management Inc. bought a new position in Danaher in the third quarter valued at $40,000. FSA Wealth Management LLC purchased a new stake in Danaher during the third quarter valued at about $50,000. Finally, Darwin Wealth Management LLC bought a new stake in Danaher in the 3rd quarter worth approximately $55,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 1.1 %

Shares of Danaher stock opened at $247.77 on Wednesday. The firm has a market cap of $178.96 billion, a price-to-earnings ratio of 47.29, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. Danaher Co. has a 52-week low of $225.42 and a 52-week high of $281.70. The company’s 50-day simple moving average is $235.75 and its 200-day simple moving average is $253.65. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio is presently 20.61%.

Analyst Ratings Changes

DHR has been the topic of a number of analyst reports. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Guggenheim assumed coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. Scotiabank assumed coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Stifel Nicolaus upped their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $285.81.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.